Epilepsy & Treatment

Global Health and Epilepsy

Epilepsy, a widespread neurological disorder affecting approximately 50 million people globally, poses significant challenges to global health due to its diverse manifestations, varying access to care, and the socio-economic impact it has on individuals and communities. In many low- and middle-income countries, epilepsy remains poorly understood, often stigmatized, and inadequately treated, leading to a substantial treatment gap where a significant number of individuals with epilepsy do not receive the necessary medical care. This disparity is compounded by a lack of resources, trained healthcare professionals, and access to antiepileptic drugs (AEDs), which are critical for effective seizure management. The World Health Organization (WHO) has recognized epilepsy as a major public health issue, emphasizing the need for comprehensive strategies to improve diagnosis, treatment, and support systems worldwide. Efforts to enhance global health and epilepsy care involve increasing awareness and education to reduce stigma, integrating epilepsy care into primary health systems, and improving the availability of medications and diagnostic tools. Public health initiatives and partnerships, such as the Global Campaign Against Epilepsy, aim to address these challenges by promoting the implementation of community-based programs, improving access to care, and supporting research into epilepsy treatment and management. Additionally, addressing the intersection of epilepsy with other health issues, such as mental health disorders, is crucial, as these comorbid conditions can significantly impact the overall well-being and quality of life of individuals with epilepsy.